AtriCure Inc

NASDAQ:ATRCUnited States

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

Contact Information

Headquarters

7555 Innovation WayMASON, OH, United States 45040

Phone

513-755-4100

Fax

513-755-4567

Executives

Independent Chairman of the Board

Robert White

President, Chief Executive Officer, Director

Michael Carrel

Chief Financial Officer

Angela Wirick

Chief Operating Officer

Douglas Seith

Chief Human Resource Officer

Deborah Yount